BioPorto Diagnostics A/S
BioPorto Diagnostics A/S Patent applications | ||
Patent application number | Title | Published |
---|---|---|
20130177923 | DIAGNOSTIC USE OF INDIVIDUAL MOLECULAR FORMS OF A BIOMARKER - Methods are provided of diagnosing, monitoring or determining the severity of disease or injury by measuring individual molecular forms of neutrophil gelatinase-associated lipocalin (NGAL) in bodily fluids, including the diagnosis and monitoring of acute renal injury leading to acute renal failure in a human or mammalian subject by determining the concentration of the free monomer form of NGAL. | 07-11-2013 |